Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2015 Mar 27;150(3):597–604. doi: 10.1007/s10549-015-3351-1

Table 1.

All AI and tamoxifen patients

Control N = 92 Yoga N = 75 P value
Age
 Mean (SE) 53.2   (0.86) 55.1   (1.24) (0.20)
Race
 Caucasian 84 (91.3 %) 74 (98.7 %)
 Non-caucasian   8   (8.7 %)   1   (1.3 %)   0.04
Education
 HS or less 19 (20.7 %) 12 (16.0 %)
 Some college 32 (34.8 %) 27 (36.0 %)   0.74
 College degree or higher 41 (44.6 %) 36 (48.0 %)
Employment
 Currently employed 78 (84.8 %) 67 (89.3 %)
 Unemployed, disabled, or retired 14 (15.2 %)   8 (10.7 %)   0.39
Marital status
 Married or long-term committed relationship 72 (78.3 %) 57 (76.0 %)
 Divorced, widowed, or separated 20 (21.7 %) 18 (24.0 %)   0.73
Stage
 0/I 48 (53.9 %) 32 (44.4 %)
 II 31 (34.8 %) 30 (41.7 %)
 III 10 (11.2 %) 10 (13.9 %)   0.48
Previous treatment
 Surgery 91 (98.9 %) 73 (97.3 %)   0.45
 Chemotherapy 56 (60.9 %) 53 (70.7 %)   0.19
 Radiotherapy 69 (75.0 %) 56 (74.7 %)   0.96
Months since first cancer treatment
 Mean (SE) 18.4   (0.67) 16.0   (0.69)   0.01
Karnofsky performance status (KPS)
 Mean (SE) 96.4   (0.90) 96.7   (0.79)   0.78